Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry
Zusammenhang zwischen Unterschieden der geschätzten GFR nach Kreatinin versus Cystatin C und Schlaganfall-Outcomes: Ergebnisse aus dem Third China National Stroke Registry
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70930 ↗Auf einen Blick
Bei 10.293 Personen mit ischämischem Schlaganfall oder transitorischer ischämischer Attacke waren größere Unterschiede zwischen eGFRcys und eGFRcr mit mehr Behinderung und Mortalität assoziiert.
Fragestellung
Ist der Unterschied zwischen cystatin C- und kreatininbasierter eGFR mit dem Schlaganfallprognose verknüpft?
Methode
Multizentrische, prospektive Kohortenstudie aus dem Third China National Stroke Registry; Analyse von eGFRabdiff, eGFRrediff und ΔeGFRdiff; Outcomes über 5 Jahre.
Ergebnisse
eGFRabdiff < −15 mL/min/1,73 m² war mit Behinderung (OR 1,19; 95 %-KI 1,05–1,35) und Mortalität (HR 1,28; 95 %-KI 1,12–1,46) assoziiert. eGFRrediff < 0,6: Behinderung OR 1,66 (95 %-KI 1,25–2,19), Mortalität HR 1,49 (95 %-KI 1,17–1,90).
Schlussfolgerung der Autor:innen
Signifikante und zunehmende eGFRdiff waren unabhängig mit einem erhöhten Risiko für post-stroke Behinderung und Mortalität assoziiert. Das unterstreicht die Bedeutung der Überwachung von eGFRcys und eGFRcr in der Schlaganfallbehandlung.
Kernaussagen
- eGFRabdiff < −15 war mit mehr Behinderung und Mortalität assoziiert
- eGFRrediff < 0,6 zeigte ebenfalls höhere Risiken
- Größere Veränderungen von eGFRdiff gingen mit höherer Mortalität einher
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.05.2026. Verfasst von Qi Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, Creatinine, Stroke. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital's Funds for Health Improvement and Research, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The effect of the difference between cystatin C‐ and creatinine‐based estimated glomerular filtration rates (eGFRdiff) on stroke outcomes is unclear. This study investigated the association between eGFRdiff and stroke prognosis.
Methods
Participants with ischaemic stroke or transient ischaemic attack were recruited from the Third China National Stroke Registry, a multicenter, prospective cohort. eGFRdiff was calculated using the absolute difference (eGFRabdiff defined as cystatin C‐based (eGFRcys) minus creatinine‐based (eGFRcr)) and the ratio (eGFRrediff) between eGFRcys and eGFRcr estimates. eGFRabdiff (< −15, −15–15, ≥ 15 mL/min/1.73 m 2 ) and eGFRrediff (< 0.6, ≥ 0.6) were analyzed. Time‐updated eGFRdiff (ΔeGFRdiff) was defined as the change from baseline to 1‐year blood re‐examination and tertiled. Outcomes included 5‐year all‐cause mortality, stroke disability, and stroke recurrence.
Results
Among 10,293 participants, 35.2% had an eGFRabdiff < −15 mL/min/1.73 m 2 , and 3.5% had an eGFRrediff < 0.6. Compared with midrange eGFRabdiff, participants with eGFRabdiff < −15 mL/min/1.73 m 2 had an odds ratio (OR) of 1.19 (95% confidence interval (CI), 1.05–1.35) for disability and a hazard ratio (HR) of 1.28 (95% CI, 1.12–1.46) for mortality. eGFRrediff < 0.6 was associated with a higher risk for disability (OR, 1.66; 95% CI, 1.25–2.19) and mortality (HR, 1.49; 95% CI, 1.17–1.90). Participants with the largest ΔeGFRdiff declines had higher mortality (OR, 1.44; 95% CI, 1.14–1.82) and borderline disability risk significance (HR, 1.25; 95% CI, 0.96–1.61).
Conclusions
Significant and widening eGFRdiff were independently associated with increased risks of post‐stroke disability and mortality, highlighting the importance of monitoring eGFRcys and eGFRcr in stroke management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China.
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.
ORCID-Profile: Qi Huang, Yuesong Pan, Xia Meng, Anxin Wang, Yilun Zhou, Yongjun Wang
Förderung
- Capital's Funds for Health Improvement and Research
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals Incubating Program
Zitieren
APA
Huang, Q., Pan, Y., Yan, H., Meng, X., Zhang, Y., Wang, M., Wang, A., Zhou, Y., & Wang, Y. (2026). Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70930
Vancouver
Huang Q, Pan Y, Yan H, Meng X, Zhang Y, Wang M, et al. Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70930
BibTeX
@article{Huang2026,
author = {Huang, Qi and Pan, Yuesong and Yan, Hongyi and Meng, Xia and Zhang, Yin and Wang, Mengxing and Wang, Anxin and Zhou, Yilun and Wang, Yongjun},
title = {Association Between Differences in Estimated GFR by Creatinine Vs. Cystatin C and Stroke Outcomes: Results From the Third China National Stroke Registry},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70930}
}
EUVIMED